Hyperammonemia in Inherited Metabolic Diseases.
Ribas GS, Lopes FF, Deon M, Vargas CR.
Cell Mol Neurobiol. 2022 Nov;42(8):2593-2610. doi: 10.1007/s10571-021-01156-6. Epub 2021 Oct 19.
Hyperammonemia in review: pathophysiology, diagnosis, and treatment.
Auron A, Brophy PD.
Pediatr Nephrol. 2012 Feb;27(2):207-22. doi: 10.1007/s00467-011-1838-5. Epub 2011 Mar 23.
Postattenuation neurologic signs after surgical attenuation of congenital portosystemic shunts in dogs: A review.
Mullins RA, Escribano Carrera A, Anderson DM, Billet JP, Brissot H, Broome C, de Rooster H, Kirby BM, Pratschke KM, Tivers MS, White RN, Yool DA, Youmans KR.
Vet Surg. 2022 Jan;51(1):23-33. doi: 10.1111/vsu.13729. Epub 2021 Sep 29.
Congenital Portosystemic Shunt Presenting As Hyperammonemia Following Fontan Operation.
Morneault K, Mathews A, Sharma P, Beasley G.
JPGN Rep. 2023 Feb 1;4(1):e282. doi: 10.1097/PG9.0000000000000282. eCollection 2023 Feb.
Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K.
Eur J Endocrinol. 2013 Mar 15;168(4):557-64. doi: 10.1530/EJE-12-0673. Print 2013 Apr.
Wiedemann-Steiner Syndrome.
Sheppard SE, Quintero-Rivera F.
2022 May 26. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
Hyperammonemia.
Batshaw ML.
Curr Probl Pediatr. 1984 Nov;14(11):1-69. doi: 10.1016/0045-9380(84)90047-1.
The hyperinsulinism/hyperammonemia syndrome.
Palladino AA, Stanley CA.
Rev Endocr Metab Disord. 2010 Sep;11(3):171-8. doi: 10.1007/s11154-010-9146-0.
Ammonia Toxicity.
Padappayil RP, Borger J.
2023 Mar 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Symptomatic hyperammonemia caused by a congenital portosystemic shunt.
Kitagawa S, Gleason WA Jr, Northrup H, Middlebrook MR, Ueberschar E.
J Pediatr. 1992 Dec;121(6):917-9. doi: 10.1016/s0022-3476(05)80341-5.
